UnitedHealth Group Incorporated $UNH Shares Sold by Hardy Reed LLC

Hardy Reed LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 59.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,396 shares of the healthcare conglomerate’s stock after selling 3,537 shares during the period. Hardy Reed LLC’s holdings in UnitedHealth Group were worth $827,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the stock. PNC Financial Services Group Inc. increased its holdings in UnitedHealth Group by 4.8% in the third quarter. PNC Financial Services Group Inc. now owns 914,521 shares of the healthcare conglomerate’s stock valued at $315,784,000 after buying an additional 42,151 shares during the last quarter. Uniting Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $247,000. Coronation Fund Managers Ltd. boosted its holdings in UnitedHealth Group by 96.0% in the third quarter. Coronation Fund Managers Ltd. now owns 78,149 shares of the healthcare conglomerate’s stock worth $26,985,000 after purchasing an additional 38,287 shares during the period. TCTC Holdings LLC raised its holdings in shares of UnitedHealth Group by 6.1% during the third quarter. TCTC Holdings LLC now owns 87,829 shares of the healthcare conglomerate’s stock worth $30,327,000 after purchasing an additional 5,060 shares during the period. Finally, Cidel Asset Management Inc. grew its position in shares of UnitedHealth Group by 21.5% during the 3rd quarter. Cidel Asset Management Inc. now owns 7,914 shares of the healthcare conglomerate’s stock valued at $2,733,000 after buying an additional 1,403 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Positive analyst revisions and forecasts — Zacks lifted several near‑term EPS estimates (notably Q1 2026) and issued a more constructive earnings outlook for FY2026/2027, supporting the view that earnings could rebound despite recent volatility. Zacks Research Issues Positive Forecast for UNH Earnings
• Positive Sentiment: Business strength from Optum expansion — coverage highlights that Optum continues to expand its services and platform, which supports UnitedHealth’s long‑term growth thesis and helps explain why some investors are buying the dip. UnitedHealth Group Incorporated (UNH) Strengthens Healthcare Platform Through Optum Expansion
• Neutral Sentiment: Mizuho trims price target but keeps Outperform — the firm cut its UNH target to $350 (from $430) after Q4 results but retained an Outperform rating, a mixed signal that reduces upside expectations but leaves institutional conviction intact. Mizuho Lowers UnitedHealth Group Incorporated (UNH) Target to $350, Maintains Outperform Rating
• Negative Sentiment: Ongoing policy and cost worries — coverage warns that a flat Medicare Advantage rate outlook and elevated medical inflation could compress margins and limit premium increases, a key reason for recent selling pressure. Flat Medicare Advantage Outlook And Revenue Drop Might Change The Case For Investing In UNH
• Negative Sentiment: Fundamental caution from independent analysis — a Seeking Alpha piece re‑examines risks (medical cost inflation, government funding constraints, delayed Optum margin recovery) and argues the current valuation may already price in higher volatility. UnitedHealth: 3 Reasons Not To Buy (Revisited)
• Negative Sentiment: Market commentary questioning further downside — analysts and writers note the recent ~18% pullback over several weeks and debate whether weakness is temporary or signals deeper issues, keeping sentiment fragile. Is There More Downside To UNH Stock?

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Piper Sandler restated an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. Royal Bank Of Canada dropped their target price on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. TD Cowen boosted their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a report on Thursday, October 30th. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research note on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Trading Up 3.2%

Shares of NYSE:UNH opened at $293.33 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a current ratio of 0.79, a quick ratio of 0.82 and a debt-to-equity ratio of 0.72. The firm has a market cap of $265.71 billion, a P/E ratio of 22.24, a P/E/G ratio of 1.35 and a beta of 0.41. The company has a 50 day moving average of $320.91 and a 200-day moving average of $323.31.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.22 billion for the quarter, compared to analysts’ expectations of $113.38 billion. During the same quarter in the previous year, the company earned $6.81 earnings per share. The firm’s quarterly revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.